Shanghai No.1 Pharmacy Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	322.59	436.42	400.03	504.93	262.28
Short-Term Investments	-	85.62	66.29	40	-
Trading Asset Securities	1.03	15.38	30.15	220.29	-
Cash & Short-Term Investments	323.62	537.41	496.47	765.22	262.28
Cash Growth	-39.78%	8.25%	-35.12%	191.75%	-48.51%
Accounts Receivable	189.88	190.15	247.57	238	133.56
Other Receivables	46.97	30.4	23.31	27.1	31.32
Receivables	236.85	220.55	270.88	265.1	164.87
Inventory	354.94	336.32	332.23	334.75	214.5
Prepaid Expenses	-	9.39	3.52	0.78	0.44
Other Current Assets	141.61	23.33	14.13	31.29	20.59
Total Current Assets	1,057	1,127	1,117	1,397	662.69
Property, Plant & Equipment	253.56	260.88	215.36	181.09	167.98
Long-Term Investments	358.86	342.74	322.45	252.47	184.14
Other Intangible Assets	36.46	38.93	41.67	43.83	46.33
Long-Term Deferred Tax Assets	26.76	24.35	26.39	35.99	12.07
Long-Term Deferred Charges	24.57	20.58	16.28	14.43	9.28
Other Long-Term Assets	264.09	165.58	123.78	114.15	251.97
Total Assets	2,021	1,980	1,863	2,039	1,334
Accounts Payable	454.1	384.14	398.59	363.69	314.8
Accrued Expenses	18.3	27.14	27.09	32.57	15.02
Short-Term Debt	49.9	95.58	101.05	320.28	-
Current Portion of Long-Term Debt	63.95	-	-	-	-
Current Portion of Leases	-	63.98	58.34	49.05	38.94
Current Income Taxes Payable	7.24	0.9	10.27	37.33	5.93
Current Unearned Revenue	2.96	5.36	5.71	25.53	2.71
Other Current Liabilities	70.05	71.05	75.74	97.91	66.64
Total Current Liabilities	666.49	648.15	676.79	926.37	444.04
Long-Term Leases	107.82	115.56	107.24	88.33	63.08
Long-Term Unearned Revenue	11.5	11.97	12.44	11.3	11.68
Pension & Post-Retirement Benefits	-	2.5	2.42	-	-
Long-Term Deferred Tax Liabilities	62.25	57.48	55.83	54.34	37.34
Other Long-Term Liabilities	2.39	-	-	0.07	0.4
Total Liabilities	850.46	835.66	854.72	1,080	556.54
Common Stock	223.09	223.09	223.09	223.09	223.09
Additional Paid-In Capital	65.53	65.53	65.19	65.19	65.19
Retained Earnings	688.65	679.98	544.95	499.18	371.24
Comprehensive Income & Other	184.02	167.01	168.22	164.22	111.4
Total Common Equity	1,161	1,136	1,001	951.67	770.92
Minority Interest	9.58	8.79	7.01	7.01	7.01
Shareholders' Equity	1,171	1,144	1,008	958.68	777.92
Total Liabilities & Equity	2,021	1,980	1,863	2,039	1,334
Total Debt	221.67	275.12	266.63	457.67	102.03
Net Cash (Debt)	101.95	262.29	229.83	307.55	160.26
Net Cash Growth	-61.13%	14.12%	-25.27%	91.91%	-51.34%
Net Cash Per Share	0.46	1.17	1.03	1.37	0.71
Filing Date Shares Outstanding	219.2	223.09	223.09	223.09	223.09
Total Common Shares Outstanding	219.2	223.09	223.09	223.09	223.09
Working Capital	390.53	478.85	440.44	470.77	218.65
Book Value Per Share	5.30	5.09	4.49	4.27	3.46
Tangible Book Value	1,125	1,097	959.77	907.85	724.58
Tangible Book Value Per Share	5.13	4.92	4.30	4.07	3.25
Buildings	-	105.19	89.34	94.76	94.76
Machinery	-	26.96	26.52	26	26.32
Construction In Progress	-	5.74	1.74	1.43	2.24

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.